+++SciFinder

[quino]

hhh

[suprachemister]

Experimental Properties: Biological Chemical Flow and Diffusion Lipinski and Related Spectra Structure-related Thermal
Top Biological Properties Value Condition Note
ADME (Absorption, Distribution, Metabolism, Excretion) See full text 1 of 7 (2) CAS
Half-Life (Biological) See full text (11) CAS
LD50 See full text (15) CAS
Median Lethal Dose(LD50) 520 mg/kg Organism: mouse Route: oral (18) CAS
Median Lethal Dose(LD50) 450 mg/kg Organism: mouse Route: oral (18) CAS
Median Lethal Dose(LD50) 390 mg/kg Organism: mouse Route: oral (18) CAS
Median Lethal Dose(LD50) 360 mg/kg Organism: mouse Route: oral (19) APC
Median Lethal Dose(LD50) 350 mg/kg Organism: mouse Route: oral (18) CAS
Minimum Inhibitory Concentration See full text (40) CAS
Top Chemical Properties Value Condition Note
Acid/Base Dissociation Constant (Ka/Kb) See full text 1 of 15 (1) CAS
logD See full text 1 of 5 (16) CAS
logP See full text 1 of 15 (10) CAS
Solubility See full text 1 of 4 (45) CAS
Top Flow and Diffusion Properties Value Condition Note
Viscosity See full text (48) CAS
Top Lipinski and Related Properties Value Condition Note
logP See full text 1 of 15 (10) CAS
Top Spectra Properties Value Condition Note
Carbon-13 NMR Spectrum See spectrum (3) WSS
Carbon-13 NMR Spectrum See spectrum (3) WSS
Carbon-13 NMR Spectrum See full text (4) CAS
IR Absorption Spectrum See spectrum (12) BIORAD
IR Absorption Spectrum See full text 1 of 13 (13) CAS
IR Spectrum See full text 1 of 2 (14) CAS
Mass Spectrum See full text 1 of 13 (17) IC
NMR Spectrum See full text (17) IC
Proton NMR Spectrum See full text 1 of 6 (6) CAS
Raman Spectrum See full text (44) CAS
UV and Visible Absorption Spectrum See full text 1 of 9 (6) CAS
UV and Visible Emission/Luminescence Spectrum See full text 1 of 2 (47) CAS
UV and Visible Spectrum See full text 1 of 2 (32) CAS
Top Structure-related Properties Value Condition Note
Crystal Lattice Parameters See full text (5) CAS
Crystal Structure See full text (6) CAS
Particle Size See full text (41) CAS
Permeability See full text 1 of 9 (42) CAS
Pore Size See full text (43) CAS
X-Ray Diffraction Pattern See full text 1 of 8 (5) CAS
Top Thermal Properties Value Condition Note
Crystallization Temperature See full text (7) CAS
Enthalpy See full text 1 of 3 (8) CAS
Entropy See full text (9) CAS
Fusion Enthalpy See full text 1 of 4 (5) CAS
Fusion Entropy See full text (10) CAS
Heat Capacity See full text (5) CAS
Melting Point 203.7 °C (20) CAS
Melting Point 202-213 °C (20) CAS
Melting Point 200.7 °C (polymorph) (5) CAS
Melting Point 200.4 °C (21) CAS
Melting Point 200.36 °C (7) CAS
Melting Point 200.3 °C (22) CAS
Melting Point 200-203 °C (23) IC
Melting Point 200-201 °C (24) IC
Melting Point 200 °C Solv: methanol (67-56-1) (25) IC
Melting Point 199.8 °C (21) CAS
Melting Point 199-201 °C (26) CAS
Melting Point 199-200 °C Solv: ethanol (64-17-5) (27) IC
Melting Point 198-200 °C (28) CAS
Melting Point 198-200 °C (29) IC
Melting Point 198-200 °C Solv: 1,4-dioxane (123-91-1) (30) CAS
Melting Point 198-200 °C (19) APC
Melting Point 198-200 °C (31) SRC
Melting Point 198 °C (14) CAS
Melting Point 198 °C (32) CAS
Melting Point 198 °C (6) CAS
Melting Point 198 °C (33) CAS
Melting Point 198 °C (34) CAS
Melting Point 198 °C (35) CAS
Melting Point 198 °C Solv: methanol (67-56-1); acetone (67-64-1)(1:1) (36) CAS
Melting Point 197.3 °C (20) CAS
Melting Point 197-200 °C (37) IC
Melting Point 154 °C (38) CAS
Melting Point 150 °C (39) CAS
Melting Point 136 °C (38) CAS
Melting Point See full text 1 of 4 (10) CAS
Thermal Analysis See full text 1 of 9 (5) CAS
Thermal Conductivity See full text (46) CAS

(1) Georgeta, Mocanu; Current Drug Delivery 2004, V1(3), P227-233 CAPLUS
(2) Perez, Miguel Angel Cabrera; European Journal of Medicinal Chemistry 2004, V39(11), P905-916 CAPLUS
(3) Whipple, Earl B.; Organic Magnetic Resonance 1977, V10, P23-5 CAPLUS
(4) Liu, Wei; Journal of Physical Chemistry B 2010, V114(49), P16641-16649 CAPLUS
(5) Drebushchak, V. A.; Journal of Thermal Analysis and Calorimetry 2006, V84(3), P643-649 CAPLUS
(6) Gehad, G. Mohamed; Vibrational Spectroscopy 2004, V36(1), P97-104 CAPLUS
(7) Pajula, Katja; Molecular Pharmaceutics 2010, V7(3), P795-804 CAPLUS
(8) Mavromoustakos, T.; Biomedical and Health Research 2002, V55(Drug Discovery and Design), P150-157 CAPLUS
(9) Wassvik, Carola M.; European Journal of Pharmaceutical Sciences 2006, V29(3-4), P294-305 CAPLUS
(10) Wassvik, Carola M.; Journal of Medicinal Chemistry 2008, V51(10), P3035-3039 CAPLUS
(11) Allegrini, Alessandro; Arzneimittel Forschung 2009, V59(8), P403-409 CAPLUS
(12) BIORAD: Infrared spectral data from the Bio-Rad/Sadtler IR Data Collection was obtained from Bio-Rad Laboratories, Philadelphia, PA (US). Copyright © Bio-Rad Laboratories. All Rights Reserved.
(13) Tripathy, M. K.; Journal of Teaching and Research in Chemistry 2004, V11(2), P88-93 CAPLUS
(14) Zayed, M. A.; Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy 2004, V60A(12), P2843-2852 CAPLUS
(15) Mirshafiey, A.; International Journal of Tissue Reactions 2004, V26(1/2), P1-7 CAPLUS
(16) Lewis, David F. V.; Journal of Enzyme Inhibition and Medicinal Chemistry 2006, V21(4), P385-389 CAPLUS
(17) Mihalic, Mladen; Acta Pharmaceutica Jugoslavica 1982, V32(1), P13-20 CAPLUS
(18) Noguchi, Yasuhiro; Yakuri to Chiryo (1973-2000) 1980, V8(12), P4639-54 CAPLUS
(19) Milne, G. W. A.; Drugs: Synonyms & Properties 2000, P1280 pp. CAPLUS
(20) Stulzer, H. K.; Pharmaceutical Chemistry Journal 2008, V42(4), P215-219 CAPLUS
(21) Drebushchak, V. A.; Journal of Thermal Analysis and Calorimetry 2006, V86(2), P303-309 CAPLUS
(22) Hughes, Laura D.; Journal of Chemical Information and Modeling 2008, V48(1), P220-232 CAPLUS
(23) Laban, Gunter; DD 260398 A3 1988 CAPLUS
(24) Svoboda, Jiri; Collection of Czechoslovak Chemical Communications 1986, V51(5), P1133-9 CAPLUS
(25) Perillo, Isabel A.; Journal of Heterocyclic Chemistry 1983, V20(1), P155-60 CAPLUS
(26) Zak, Bohumil; CS 276217 B6 1992 CAPLUS
(27) Dalla Croce, Piero; Journal of Chemical Research, Synopses 1986, (4), P150-1 CAPLUS
(28) Vemavarapu, Chandra; Powder Technology 2009, V189(3), P444-453 CAPLUS
(29) Sanghavi, N. M.; Indian Journal of Technology 1989, V27(2), P93-5 CAPLUS
(30) Zia-ur-Rehman, Muhammad; Bulletin of the Korean Chemical Society 2005, V26(11), P1771-1775 CAPLUS
(31) "PhysProp" data are provided by Syracuse Research Corporation of Syracuse, New York (US)
(32) Mohamed, Gehad G.; Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy 2004, V60A(13), P3141-3154 CAPLUS
(33) Zayed, M. A.; Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy 2006, V64A(1), P216-232 CAPLUS
(34) Habibi-Yangjeh, Aziz; Bulletin of the Korean Chemical Society 2008, V29(4), P833-841 CAPLUS
(35) Mahlin, Denny; Molecular Pharmaceutics 2011, V8(2), P498-506 CAPLUS
(36) Kozjek, Franc; Acta Pharmaceutica Jugoslavica 1985, V35(4), P275-81 CAPLUS
(37) Laban, Gunter; DD 258532 A3 1988 CAPLUS
(38) Caira, Mino R.; Journal of Pharmaceutical Sciences 1998, V87(12), P1608-1614 CAPLUS
(39) Mohamed, Gehad G.; Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy 2005, V62A(4-5), P1165-1171 CAPLUS
(40) Kovala-Demertzi, Dimitra; Journal of Organometallic Chemistry 2006, V691(8), P1767-1774 CAPLUS
(41) Attama, Anthony A.; International Journal of Pharmaceutics 2005, V304(1-2), P4-10 CAPLUS
(42) Ottaviani, Giorgio; Journal of Medicinal Chemistry 2006, V49(13), P3948-3954 CAPLUS
(43) Fu, Tingming; Applied Surface Science 2010, V256(23), P6963-6968 CAPLUS
(44) Childs, Scott L.; Crystal Growth & Design 2007, V7(7), P1291-1304 CAPLUS
(45) Bard, Bruno; European Journal of Pharmaceutical Sciences 2008, V33(3), P230-240 CAPLUS
(46) Lin, Yannan; Journal of Pharmaceutical and Biomedical Analysis 2010, V51(4), P979-984 CAPLUS
(47) Albert-Garcia, J. R.; Talanta 2009, V79(2), P412-418 CAPLUS
(48) Jug, Mario; Acta Pharmaceutica (Zagreb, Croatia) 2005, V55(3), P223-236 CAPLUS